Aristo Bio-Tech and Lifescience last traded at ₹94.00 (2026-10-13). Over the past month the stock moved -13.0%, three months the stock moved -14.4%, year the stock moved -27.7%. Its closing range over 52 weeks is ₹78.55 – ₹135.00, with the latest close 30.4% below the high.
Closing prices up to 2026-10-13.
Incorporated in 2005, Aristo Bio-Tech and Lifescience Ltd manufactures and supplies pesticides and agrochemicals[1]
Business Overview:[1] ABTL, an ISO 9001:2008 certified company, manufactures, formulates, supplies, and packages various pesticides, including insecticides, herbicides, fungicides, plant growth regulators, and other agrochemicals. It currently has 257 products registered with CIB&RC for manufacturing and sales, serving both domestic and international customers.
In the latest quarter (Mar 2026), Aristo Bio-Tech and Lifescience reported sales of ₹107.00 crore (-4.5%) and net profit of ₹3.00 crore (+200.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 107.00 | 8.00 | 8.00 | 3.00 | 4.42 |
| Sep 2025 | 256.00 | 8.00 | 3.10 | 4.00 | 6.13 |
| Mar 2025 | 104.00 | 1.00 | 1.10 | 0.00 | -0.72 |
| Sep 2024 | 214.00 | 8.00 | 3.80 | 5.00 | 6.68 |
| Mar 2024 | 112.00 | 3.00 | 2.90 | 1.00 | 1.94 |
| Sep 2023 | 133.00 | 5.00 | 4.00 | 3.00 | 3.78 |
| Mar 2023 | 89.00 | 4.00 | 4.10 | 1.00 | 1.47 |
| Sep 2022 | 129.00 | 5.00 | 3.90 | 3.00 | 3.80 |
| Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales growth | +53.4% | +65.9% | +16.9% | +92.5% | -4.5% |
| Operating profit growth | +200.0% | +60.0% | -75.0% | +60.0% | +166.7% |
| Net profit growth | – | +66.7% | -100.0% | +33.3% | +200.0% |
| EPS growth | – | +75.8% | -149.0% | +62.2% | +127.8% |
| OPM % | 2.9% | 3.8% | 1.1% | 3.1% | 8.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Aristo Bio-Tech and Lifescience reported sales of ₹364.00 crore (+14.5%) and net profit of ₹7.00 crore (+75.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 364.00 | 16.00 | 4.00 | 7.00 | 10.55 |
| Mar 2025 | 318.00 | 9.00 | 3.00 | 4.00 | 5.96 |
| Mar 2024 | 245.00 | 8.00 | 3.00 | 4.00 | 5.73 |
| Mar 2023 | 218.00 | 9.00 | 4.00 | 4.00 | 5.23 |
| Mar 2022 | 166.00 | 5.00 | 3.00 | 1.00 | 2.10 |
| Mar 2021 | 167.00 | 4.00 | 3.00 | 1.00 | 2.16 |
| Mar 2020 | 201.00 | 5.00 | 2.00 | 1.00 | 2.02 |
| Mar 2019 | 202.00 | 7.00 | 3.00 | 3.00 | 5.67 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -25.5% | -0.5% | -16.9% | -0.6% | +31.3% | +12.4% | +29.8% | +14.5% |
| Operating profit growth | +0.0% | -28.6% | -20.0% | +25.0% | +80.0% | -11.1% | +12.5% | +77.8% |
| Net profit growth | -25.0% | -66.7% | +0.0% | +0.0% | +300.0% | +0.0% | +0.0% | +75.0% |
| EPS growth | -84.9% | -64.4% | +6.9% | -2.8% | +149.0% | +9.6% | +4.0% | +77.0% |
| OPM % | 3.0% | 2.0% | 3.0% | 3.0% | 4.0% | 3.0% | 3.0% | 4.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Aristo Bio-Tech and Lifescience.
Get Free AI Stock Analysis FREE →No recent news available for Aristo Bio-Tech and Lifescience.
Aristo Bio-Tech and Lifescience shares were last quoted at ₹94.00 (+0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Aristo Bio-Tech and Lifescience has a price-to-earnings (P/E) ratio of 10.62 and a price-to-book (P/B) ratio of 1.71. The industry P/E is 35.48.
The 52-week high of Aristo Bio-Tech and Lifescience is ₹136.00 and the 52-week low is ₹74.30.
The market capitalisation of Aristo Bio-Tech and Lifescience is about ₹76.25 crore.
In the latest quarter (Mar 2026), Aristo Bio-Tech and Lifescience reported sales of ₹107.00 crore (-4.5%) and net profit of ₹3.00 crore (+200.0%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Aristo Bio-Tech and Lifescience has a 3-year ROE of 14.00%, 3-year profit growth of 26.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 73.42% of Aristo Bio-Tech and Lifescience.
Aristo Bio-Tech and Lifescience belongs to the Pesticides & Agrochemicals sector.
All Pesticides & Agrochemicals stocks · Browse all stocks A–Z